CEMTREX SUBSIDIARY, INVOCON, SELECTED FOR U.S. NAVY SBIR PHASE I CONTRACT IN NAVAL MINE WARFARE
April 7, 2026
Technology
-
-
TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company’s Runway into Late 2027/Early 2028
April 7, 2026
-
AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
April 7, 2026
-
Nuvini to Acquire 51% Controlling Stake in the American business of Beyondsoft Corporation, Creating a $148M Global Technology Platform
April 6, 2026
-
Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing
April 6, 2026
-
Quantum-Si Announces the Start of the Proteus(TM) Roadshow
April 6, 2026
-
Mobix Labs: $3.2M Order Received for Technology Used in TSA Airport Scanners
April 6, 2026
-
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
April 3, 2026
-
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026
April 3, 2026
-
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
April 2, 2026
-
Enterprises Align AI and Data Platforms to Scale AI Deployments with Accuracy, Compliance, ISG says
April 2, 2026
-
Global Counter-UAS Interceptor Market Surges Amid Escalating Drone Warfare Threats
April 2, 2026
-
INOVIO Announces Pricing of $17.5 Million Public Offering
April 2, 2026
-
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
April 2, 2026
-
Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform
April 2, 2026
-
Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update
April 2, 2026